TP53 and cancer: Finally, NRF2 dysregulated may contribute to tumorigenesis by suppressing apoptosis and promoting cancer cell survival via the tumor protein 53 (p53), often referred to as the “guardian of the genome” due its crucial role in maintaining genomic integrity [48,49].